FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Wednesday

 

Prenatal Vitamin D and Risk for MS
































Image Source: HEALTHTAP

Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort


Although adequate vitamin D levels have been linked to lower risk for multiple sclerosis (MS) in adulthood, previous research has been conflicting regarding the association of prenatal vitamin D status with subsequent MS risk. The goal of this prospective, nested case-control study was to evaluate the association of maternal serum 25-hydroxy vitamin D (25[OH]D) levels in early pregnancy with risk for MS in the offspring.

Using the Finnish Maternity Cohort, researchers identified 193 patients (about 84% were female) diagnosed with MS before December 31, 2009, whose mothers were enrolled in this cohort and had an available serum sample from the pregnancy with the affected child. Seventy percent of these samples were obtained during the first trimester. The investigators matched 176 cases with 326 controls, based on Finnish birth region and dates of maternal serum sample collection, mother's birth, and child's birth.

Mean maternal vitamin D levels, based on chemiluminescence assay, were in the insufficient vitamin D range overall, although they were higher in controls relative to cases (15.02 ± 6.41 ng/mL vs 13.86 ± 5.49 ng/mL). Compared with mothers who did not have deficient 25(OH)D levels during early pregnancy, those who had deficient levels (< 12.02 ng/mL) had nearly twice the risk for MS in their offspring (relative risk [RR]: 1.90; 95% confidence interval [CI], 1.20-3.01; P = .04), based on conditional logistic regression with adjustment for sex of the offspring, gestational age at sample collection, and season of sample collection. MS risk was not significantly associated with increased serum 25(OH)D levels (RR: 0.52; 95% CI, 0.22-1.19; P = .12).

Viewpoint

Study limitations include the use of maternal 25(OH)D levels as a proxy measure for fetal vitamin D status, sample collection mostly during the first trimester, lack of data on other MS risk factors, and young age at MS diagnosis (mean: 19.8-27 years). It is therefore possible that the association between maternal 25(OH)D levels during pregnancy and MS incidence decreases at older ages. In addition, this study did not examine 25(OH)D levels during childhood and early adulthood of the offspring who ultimately developed MS. Despite these limitations, these findings suggest that detecting and correcting maternal vitamin D deficiency in early pregnancy may help reduce risk for MS in their offspring.

Although mechanisms underlying this association are still undetermined, one possible mechanism might involve the effect of vitamin D receptor activation on suppression of interleukin-17 and proinflammatory T cells. A second potential mechanism may be the effect of vitamin D deficiency on myelinogenesis, as vitamin D may be a necessary cofactor in lipid metabolism during myelin formation in early development.

Story Source: The above story is based on materials provided by MEDSCAPE
Note: Materials may be edited for content and length

Labels: , ,



Go to Newer News Go to Older News